Inbiose
Universiteit Gent

Inbiose

Biotech
Biotech
Biotech
Biotech

Inbiose develops a fermentation-based production platform for the supply of specialty carbohydrates addressing wellness, nutrition, AgBio and BioMed needs.

Inbiose was founded mid 2013 as a spin-off from Ghent University. Inbiose develops a versatile fermentation-based production platform for the supply of specialty carbohydrates addressing wellness, nutrition, AgBio and BioMed needs. Specialty carbohydrates are high value added, rare and complex carbohydrates that are extremely hard to produce with conventional technologies (extraction, chemical or enzymatic synthesis). Though these powerful ingredients have been found to be essential for improving health in many areas, applications were hampered until today by the production cost and very limited availability. Inbiose can now tackle these technological issues, giving strong and reliable market perspectives.

No items found.
Marc Zabeau

Marc Zabeau

Managing Partner Qbic I

This company is aligned with the following SDGs

No items found.
Axithra
Qbic III
HealthTech
HealthTech
HealthTech
HealthTech

Axithra

Axithra is developing new technology for accurate drug concentrations in blood.

Universiteit Gent
imec
Animab
Qbic III
Biotech
Biotech
Biotech
Biotech

Animab

Animab develops antibodies to tackle gastrointestinal pathogens in livestock.

Universiteit Gent
VUB
Innocens
Qbic III
HealthTech
HealthTech
HealthTech
HealthTech

Innocens

Helping clinicians make faster, smarter decisions with AI-powered alerts for patient deterioration.

Universiteit Antwerpen
UZ Antwerpen